Ramachary-Bressy-Wang [3+2]cycloaddition reaction: Synthesis of fully decorated 1,2,3-triazoles as potent anticancer and EGFR inhibitors

[1]  R. M.,et al.  Benzothiazole-[1,2,3]triazolo[5,1-a]isoindoles: Synthesis, Anticancer activity, Bioavailability and in silico studies against Gama-Tubulin protein , 2021, Journal of Molecular Structure.

[2]  M. El-Mansy,et al.  Angiokinase Inhibition of VEGFR-2, PDGFR and FGFR and Cell Growth Inhibition in Lung Cancer: Design, Synthesis, Biological Evaluation and Molecular Docking of Novel Azaheterocyclic Coumarin Derivatives. , 2021, Bioorganic & medicinal chemistry letters.

[3]  Gondru Ramesh,et al.  Fused benzo[1,3]thiazine-1,2,3-triazole hybrids: Microwave-assisted one-pot synthesis, in vitro antibacterial, antibiofilm, and in silico ADME studies. , 2021, Bioorganic & medicinal chemistry letters.

[4]  E. S. Nossier,et al.  Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR , 2021, Journal of enzyme inhibition and medicinal chemistry.

[5]  D. Chetia,et al.  A Simple Work-Up-free, Solvent-free Approach to Novel Amino Acid Linked 1,4-Disubstituted 1,2,3-Triazoles as Potent Antituberculosis Agents , 2020, ACS omega.

[6]  T. Al-Warhi,et al.  Recent advancements of coumarin-based anticancer agents: An up-to-date review. , 2020, Bioorganic chemistry.

[7]  Zhi Xu.  1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). , 2020, European journal of medicinal chemistry.

[8]  Heba Abdel-Fatah Ibrahim,et al.  Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy , 2020, Future Journal of Pharmaceutical Sciences.

[9]  M. Ravinder,et al.  One‐pot synthesis and biological evaluation of novel 4‐[3‐fluoro‐4‐(morpholin‐4‐yl)]phenyl‐1 H ‐1,2,3‐triazole derivatives as potent antibacterial and anticancer agents , 2020 .

[10]  Zhi Xu,et al.  1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. , 2019, European journal of medicinal chemistry.

[11]  H. Aisa,et al.  1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview , 2019, Bioorganic & Medicinal Chemistry.

[12]  A. Onay-Beşikci,et al.  Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors. , 2019, European journal of medicinal chemistry.

[13]  B. Narasimhan,et al.  Benzimidazole scaffolds as promising antiproliferative agents: a review , 2019, BMC Chemistry.

[14]  Y. Reddy,et al.  Microwave-assisted Cu-catalyzed C–C bond formation: one-pot synthesis of fully substituted 1,2,3-triazoles using nonsymmetrical iodoalkynes and their biological evaluation , 2018, Chemistry of Heterocyclic Compounds.

[15]  K. D. Saha,et al.  Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent , 2018, ACS omega.

[16]  A. Asiri,et al.  Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review. , 2018, Anti-cancer agents in medicinal chemistry.

[17]  A. Saxena,et al.  Synthesis and Characterization of Chalcone‐Pyridinium Hybrids as Potential Anti‐Cancer and Anti‐Microbial Agents , 2018 .

[18]  Y. Reddy,et al.  Synthesis and Biological Evaluation of (N‐(3‐methoxyphenyl)‐4‐((aryl‐1H‐1,2,3‐triazol‐4‐yl)methyl)thiomorpholine‐2‐carboxamide 1,1‐Dioxide Hybrids as Antiproliferative Agents , 2017 .

[19]  A. Buragohain,et al.  Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents. , 2017, Bioorganic & medicinal chemistry letters.

[20]  Y. Reddy,et al.  Synthesis and Biological Evaluation of Novel Thiomorpholine 1,1-Dioxide Derived 1,2,3-Triazole Hybrids as Potential Anticancer Agents , 2017 .

[21]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[22]  D. Ramachary,et al.  Organocatalytic Vinyl Azide‐Carbonyl [3+2] Cycloaddition: High‐Yielding Synthesis of Fully Decorated N‐Vinyl‐1,2,3‐Triazoles , 2017 .

[23]  D. Ramachary,et al.  Triazabicyclodecene as an Organocatalyst for the Regiospecific Synthesis of 1,4,5‐Trisubstituted N‐Vinyl‐1,2,3‐triazoles , 2017 .

[24]  Tatjana Gazivoda Kraljević,et al.  Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. , 2016, European journal of medicinal chemistry.

[25]  K. Abouzid,et al.  Design and Synthesis of 4‐Anilinothieno[2,3‐d]pyrimidine‐Based Compounds as Dual EGFR/HER‐2 Inhibitors , 2016, Archiv der Pharmazie.

[26]  Y. Reddy,et al.  Synthesis, characterization and biological evaluation of 7-substituted- 4-((1-aryl-1H-1,2,3-triazol-4-yl) methyl)-2H-benzo[b][1,4]oxazin- 3(4H)-ones as anticancer agents , 2016, Medicinal Chemistry Research.

[27]  M. S. Rao,et al.  Synthesis and antimicrobial evaluation of some novel thiomorpholine derived 1,4-disubstituted 1,2,3-triazoles , 2016 .

[28]  N. Vasudeva Reddy,et al.  Indole-2-carboxylic acid derived mono and bis 1,4-disubstituted 1,2,3-triazoles: Synthesis, characterization and evaluation of anticancer, antibacterial, and DNA-cleavage activities. , 2016, Bioorganic & medicinal chemistry letters.

[29]  B. B. Mishra,et al.  Cu-Catalyzed Click Reaction in Carbohydrate Chemistry. , 2016, Chemical reviews.

[30]  D. Ramachary,et al.  An Organocatalytic Regiospecific Synthesis of 1,5-Disubstituted 4-Thio-1,2,3-triazoles and 1,5-Disubstituted 1,2,3-Triazoles. , 2015, Chemistry.

[31]  M. Kaur,et al.  Coumarin: a promising scaffold for anticancer agents. , 2015, Anti-cancer agents in medicinal chemistry.

[32]  R. Singla,et al.  Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. , 2015, European journal of medicinal chemistry.

[33]  Douglas E. V. Pires,et al.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.

[34]  Z. Du,et al.  Organocatalytic 1,3-dipolar cycloaddition reaction of α,β-unsaturated ketones with azides through iminium catalysis , 2015 .

[35]  D. Ramachary,et al.  An enolate-mediated organocatalytic azide-ketone [3+2]-cycloaddition reaction: regioselective high-yielding synthesis of fully decorated 1,2,3-triazoles. , 2014, Chemistry.

[36]  Meng‐Yang Chang,et al.  One-pot access to sulfonylmethyl arylpyrroles via the domino aerobic Wacker-type aminocyclization/1,4-sulfonyl migration. , 2014, Organic letters.

[37]  D. Ramachary,et al.  An organocatalytic azide-aldehyde [3+2] cycloaddition: high-yielding regioselective synthesis of 1,4-disubstituted 1,2,3-triazoles. , 2014, Angewandte Chemie.

[38]  Z. Du,et al.  Direct access to 1,2,3-triazoles through organocatalytic 1,3-dipolar cycloaddition reaction of allyl ketones with azides , 2014 .

[39]  Z. Du,et al.  Direct access to triazole-olefins through catalytic cycloaddition of azides to unsaturated aldehydes. , 2013, Chemical communications.

[40]  D. Ramachary,et al.  Organocatalytic triazole formation, followed by oxidative aromatization: regioselective metal-free synthesis of benzotriazoles. , 2013, Chemistry.

[41]  Shaofa Sun,et al.  Organocatalytic 1,3-dipolar cycloaddition reactions of ketones and azides with water as a solvent , 2013 .

[42]  Vijay Luxami,et al.  Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. , 2013, Bioorganic & medicinal chemistry letters.

[43]  Yaojun Gao,et al.  Amine-catalyzed [3+2] Huisgen cycloaddition strategy for the efficient assembly of highly substituted 1,2,3-triazoles. , 2012, Chemistry.

[44]  Cyril Bressy,et al.  Organocatalytic synthesis of 1,2,3-triazoles from unactivated ketones and arylazides. , 2011, Chemistry.

[45]  V. Pore,et al.  Click chemistry: 1,2,3-triazoles as pharmacophores. , 2011, Chemistry, an Asian journal.

[46]  B. Potter,et al.  Structure–Activity Relationship for the First-in-Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495) , 2011, ChemMedChem.

[47]  Yuzong Chen,et al.  Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors. , 2011, Bioorganic & medicinal chemistry.

[48]  Maoguo Li,et al.  Organocatalytic enamide-azide cycloaddition reactions: regiospecific synthesis of 1,4,5-trisubstituted-1,2,3-triazoles. , 2011, Chemistry.

[49]  Atul Kumar,et al.  Synthesis of chalcones and flavanones using Julia–Kocienski olefination , 2010 .

[50]  B. Blagg,et al.  Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues. , 2010, Bioorganic & medicinal chemistry letters.

[51]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[52]  D. Ramachary,et al.  Amino acid-catalyzed cascade [3+2]-cycloaddition/hydrolysis reactions based on the push-pull dienamine platform: synthesis of highly functionalized NH-1,2,3-triazoles. , 2008, Chemistry.

[53]  G. Tortora,et al.  Rational bases for the development of EGFR inhibitors for cancer treatment. , 2007, The international journal of biochemistry & cell biology.

[54]  E. Barreiro,et al.  Molecular hybridization: a useful tool in the design of new drug prototypes. , 2007, Current medicinal chemistry.

[55]  Herbert Waldmann,et al.  Charting Biological and Chemical Space: PSSC and SCONP as Guiding Principles for the Development of Compound Collections Based on Natural Product Scaffolds , 2006 .

[56]  R. Coombes,et al.  Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor , 2006, Clinical Cancer Research.

[57]  G. Tortora,et al.  Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. , 2003, European journal of cancer.

[58]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[59]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[60]  E. Kohn,et al.  Identification and characterization of human metabolites of CAI [5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide). , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[61]  T. Mandai,et al.  Novel synthesis of acetylenes and polyenes via a desulfonylation reaction , 1984 .